.

Competition #2 Judges

We are privileged to work with an expert set of judges who will ensure a fair and rigorous competition. Their professional insight will be imperative as we look to award teams who have successfully demonstrated innovative solutions that will advance essential sensing technologies.

    

COMPETITION #2 Judges



Mary Czerwinski, PhD

Mary Czerwinski is a Research Manager of the Visualization and Interaction (VIBE) Research Group. Dr. Mary Czerwinski's background is in visual attention, but her research focuses primarily on emotion tracking for health and wellbeing, information worker task management and awareness systems for individuals and groups. Dr. Czerwinski holds a Ph.D. in Cognitive Psychology from Indiana University in Bloomington. She was awarded the ACM SIGCHI Lifetime Service Award, was inducted into the CHI Academy, and became an ACM Distinguished Scientist in 2010. She received the Distinguished Alumni Award for Indiana University’s Psychology department in 2013 and currently sits on various academic advisory boards.
    



Carlos Grodsinsky, PhD

Dr. Carlos Grodsinsky is a principal and Chief Operations and Technology Officer of ZIN Technologies having over 25 years’ experience with IR&D, R&D, and product development/commercialization of active/passive vibration control, radiation detection, space flight physical and life science instrumentation and remote patient medical technologies. Dr. Godsinsky has managed large programs and product development initiatives within both government and industry, with a proven record of successful technology development, transfer, and new product introductions both for government and private industry. He is a recognized expert in advanced dynamics, reduced gravity acceleration environments and control for ground and space based experimentation. Most recently Dr. Grodsinsky leads a successful start-up co-owned by ZIN Technologies (ZIN) and The Cleveland Clinic (CC) offering remote patient management services based on astronaut health monitoring and countermeasure technologies commercialized by ZIN and CC.

Dr. Grodsinsky previously managed R&D for Optics and Oxides and the Radiation Detector business (medical, physics, and energy exploration) for Saint Gobain Crystals and Detectors. Dr. Grodsinsky earned a Ph.D., and M.S. in Mechanical and Aerospace Engineering from Case Western Reserve University, a BS in Mechanical Engineering from Wayne State University, and a BA in Physics/Mathematics from Kalamazoo College.
    



Michael Kass, PhD

Dr. Michael Kass is a computer scientist with interests that include computer graphics, computer vision, computational photography and robotics. His 1988 computer vision paper "Snakes, Active Contour Models" is listed by CiteSeer as the 11th most cited article in computer science. In 2005, Dr. Kass received a Scientific and Technical Academy Award for "Pioneering work in physically-based computer-generated techniques used to simulate realistic cloth in motion pictures." In 2009, he received the ACM SIGGRAPH Computer Graphics Achievement Award "for his extensive and significant contributions to computer graphics, ranging from image processing to animation to modeling, and in particular for his use of optimization for physical simulation and image segmentation.

Dr. Kass received his B.A. from Princeton in 1982, his M.S. from M.I.T. in 1984, and his Ph.D. from Stanford in 1988. He has received several conference best paper awards, the Prix Ars Electronica for the image "Reaction Diffusion Texture Buttons," and the Imagina Grand Prix for the animation "Splash Dance." He holds 14 U.S. patents. Dr. Kass spent 18 years as a senior research scientist at Pixar. Prior to that, he held research positions at Schlumberger Palo Alto Research and Apple Computer. In addition to his professional achievements, Dr. Kass was the 1980 U.S. Juggling Champion and the 2003 U.S. Adult National Silver Medalist in ice dance.
    



Matthew Lorence, PhD

Dr. Matthew Lorence has 20 years of experience in the molecular diagnostic and genomics tools industries, with extensive knowledge of genomic technologies, including NGS and Sanger sequencing, RT-PCR, and microarrays, and the CLIA regulations related to the development of LDTs based on these technologies. Dr. Lorence has led the development and commercialization of molecular diagnostic assays throughout his career, including the Emergency Use Authorized RM-Flu assay for the 2009 H1N1 Flu virus while at TessArae, and the MicroSeq system for the identification of microbial contamination in the pharmaceutical manufacturing industry, as well as leading the collaboration with Cepheid to provide biothreat pathogen detection consumables to the US Postal Service while at Applied Biosystems. While at Bio-Rad Laboratories, he was responsible for the pulsed field gel electrophoresis systems used by the CDC for epidemiological analysis of foodborne pathogens (PulseNet). Dr. Lorence is an original member of the Scientific Advisory Board for the Enabling Point-of-Care Diagnostics Conference organized by Cambridge HeathTech and the ATCC Standards Development Organization. He has authored 20 publications in peer-reviewed journals, and given presentations at numerous international conferences and symposia. Dr. Lorence earned an AB in Genetics and Psychology from the University of California at Berkeley, and a Ph.D. in Molecular Biology from the University of Texas at Dallas. As an NIH postdoctoral fellow at the University of Texas Southwestern Medical Center at Dallas, he earned an MBA with concentrations in Marketing and Business Strategy from the Naveen Jindal School of Management at the University of Texas at Dallas.
    



Robert Matthews, PhD

In his role as Chief Executive Officer (CEO) of NudgeWorX, Dr. Robert Matthews is working to develop the next generation of health tools that encourage people to adopt and keep good health behaviors. The company is presently working on tools/methods to help parents and their children deal with childhood obesity -currently a worldwide epidemic.

Dr. Matthews is an accomplished, hands-on executive with a 20-year track record of leading and driving highly innovative, successful organizations. Dr. Matthews raised over $100M in research revenue from government and private investors, founded seven companies, and developed and brought to market more than 12 products, including six medical devices. He is inventor or co-inventor on 20 patents. Rob’s success stems from his ability to analyze an organization's critical business requirements, identify potential opportunities and risks, and bring together cross-functional high performance teams to develop innovative, cost-effective solutions. These solutions have expanded markets, created new opportunities, enhanced competitiveness, and improved customer satisfaction.

Dr. Matthews brings extensive experience in the research and development of state-of-the-art instrumentation, and solving complex problems in the health care, humanitarian and wellness industries. He has in-depth experience in developing non-invasive medical devices and a broad range of practical experience in developing state of the art EM (electromagnetic) sensing systems. An outstanding inventor and an expert in ultra-low noise electronics, Dr. Matthews is the author and coauthor on many scientific publications. He is also an Executive Board member of the Augmented Condition Society and also belongs to the Human Factor Ergonomic Society. He earned his Ph.D. in Physics from the University of Western Australia.
    



Megan Moynahan

Megan Moynahan is the Executive Director of the Institute for Functional Restoration, a non-profit organization with the mission to restore function to people with paralysis by creating a sustainable business model for sophisticated medical technologies. The IFR is creating an innovative for-profit/non-profit business model that will allow the translation of neuromodulation systems through the necessary commercialization steps using funding that comes from a combination of grants, philanthropy and revenue.

Prior to this, Megan enjoyed a 17-year career at the US Food and Drug Administration’s Center for Devices and Radiological Health, where she served as its Associate Director for Technology and Innovation, leading a variety of projects including directing the White House sponsored Entrepreneurs-in-Residence program at FDA, and the Innovation Pathway program designed to streamline the regulatory process for innovative medical devices. Her past experience includes serving as the chief of FDA’s Pacemaker and Defibrillator branch from 2001-2007, launching national initiatives for external defibrillators, implantable pacemaker leads, and other device safety measures. She holds a Bachelor’s degree in Biomedical Engineering from Johns Hopkins University and a Master’s degree in Biomedical Engineering from Case Western Reserve University.
    



Rosibel Ochoa, PhD

Dr. Rosibel Ochoa is the Executive Director of the von Liebig Entrepreneurism Center at University of California, San Diego. Dr Ochoa has adapted the von Liebig Center proof of concept model into a commercialization program that has been leveraged by universities and research institutes in Southern California.

During her tenure the program has supported more than 75 entrepreneurial teams and more than 20 of these teams have started their own companies. She was instrumental in the launch of the Triton Technology Fund, an early stage investment vehicle to support startups affiliated to University of California, San Diego. In the spring of 2014, she joined the Triton Fund as member of the investment committee.

She is the Site Manager of the NSF’s funded I-Corps site at University of California, San Diego(2013). She is the Co- Director of My Startup XX (2011), a fellowship program for female engineering and business students interested in pursuing entrepreneurship. This program received the 2014 Pinnacle Award from Athena San Diego, in the category of program/organization.

Rosibel received her Bachelor of Science from the National University of Honduras, and her Master of Science and Ph.D. in Chemical Engineering from the University of Louisville and has served as an expert consultant to the American Development Bank and the OAS.

She is also a Member of a Task Force on Innovation and Entrepreneurship for the VIII Americas Competitiveness Forum She was nominated by Athena San Diego for the 2014 Pinnacle Award in Education and has received several awards at Motorola Energy Systems Group for Innovation and Excellence in Total Customer Satisfaction.
    



Lada Rasochova, PhD

Dr. Lada Rasochova is the Executive Director of the California Institute for Innovation and Development, managing director of the Rady Venture Fund and director of StartR accelerator at the Rady School of Management at the University of California, San Diego. Dr. Rasochova has been involved in commercialization of pharmaceutical and biotechnology products for the past 20 years. Dr. Rasochova spent more than 15 years in industry where she held various scientific and leadership positions. Dr. Rasochova was the leader of Vaccine Technologies and director of New Business Development in the Dowpharma division of the Dow Chemical Company. She managed multimillion dollar R&D programs including a program focused on the development of the next generation human vaccines. After joining the University of California, San Diego in 2008, Dr. Rasochova co-founded the California Institute for Innovation that serves as a hub for innovation, entrepreneurial education and technology commercialization on campus. She also co-founded the Rady Venture Fund, a venture capital fund at the University of California, San Diego that invests in early stage technology ventures and StartR accelerator that provides support to emerging startup companies. In addition to leading the technology commercialization efforts, Dr. Rasochova teaches graduate level courses in Technology Commercialization and Venture Capital Management and serves on boards of several startup companies. Dr. Rasochova received her Ph.D. in molecular, cellular, and developmental biology from Iowa State University and MBA from the Rady School of Management at University of California, San Diego. She is an inventor on several patents.


    



Eric Van Gieson, PhD

Dr. Eric Van Gieson is presently with MRIGLobal, serving as Director of Biosurveillance and Diagnostics Innovation. He most recently served as Division Chief of the Diagnostics, Disease Surveillance, and Threat Detection Division within the Defense Threat Reduction Agency (DTRA) where he is worked across industry and the interagency to foster the linkage of home-use and point of care diagnostics with health surveillance capabilities, especially in resource-limited environments.

Prior to serving in DTRA, he has served as a program manager for military diagnostics within the Johns Hopkins Applied Physics Laboratory (JHU-APL). Dr. Van Gieson has PhD in Biomedical Engineering and a BS in Chemical Engineering from the University of Virginia. He has worked in both industry and government settings and has publications on topics ranging from genomic analysis to unmanned systems autonomy. He led several technology survey efforts for the DOD in diagnostics and has reviewed for several major diagnostics acquisition and S&T programs.

    



Noam Ziv

Noam Ziv is the founder of Kesembe Inc., and an innovator and a thought leader in the space of wireless health.

Noam enjoyed a 22 year career at Qualcomm, and was the main inventor and architect of several key wireless health platforms, as well as participating in developing strategies, partnerships, and technologies to successfully engage Qualcomm in the healthcare space.

During his early days at Qualcomm, Noam was a member of the team that invented and implemented the use of CDMA for cellular communications. He contributed to the architecture, design and implementation of ASICs, software, hardware, systems and protocols in various roles, eventually becoming the project engineer for Qualcomm’s cellular infrastructure product.

As Vice President of Engineering, Noam headed Qualcomm’s Research and Development (CR&D) Software group from 1999 to 2008 and was a contributor to virtually all of the projects undertaken by the division.

Noam attended the Technion – Israel Institute of Technology in Haifa, Israel where he earned a Bachelor of Science in Computer Engineering, and has been granted over 20 patents.

Become a Part of the Future! Sign Up for Our Newsletter: